T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Match Group
MTCH
|
+$3.17B |
| 2 |
Nike
NKE
|
+$1.94B |
| 3 |
Bank of America
BAC
|
+$1.84B |
| 4 |
FedEx
FDX
|
+$1.78B |
| 5 |
PNC Financial Services
PNC
|
+$1.61B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPLI
People Inc
PPLI
|
+$4.1B |
| 2 |
Fortive
FTV
|
+$2.54B |
| 3 |
Linde
LIN
|
+$1.53B |
| 4 |
Alibaba
BABA
|
+$1.35B |
| 5 |
Willis Towers Watson
WTW
|
+$1.13B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.61% |
| 2 | Healthcare | 16.74% |
| 3 | Consumer Discretionary | 15.8% |
| 4 | Financials | 11.46% |
| 5 | Communication Services | 10.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1026
Schrodinger
SDGR
$1.38B
| $31M | ﹤0.01% |
652,317
-99,640
| -13% | -$6.85M |
|
1027
Amcor
AMCR
$21.4B
| $31M | ﹤0.01% |
560,575
-28,982
| -5% | -$1.58M |
|
1028
Onto Innovation
ONTO
$20.6B
| $30.9M | ﹤0.01% |
1,035,924
-58,590
| -5% | -$1.94M |
|
1029
Independent Bank
INDB
$4.05B
| $30.6M | ﹤0.01% |
584,534
-76,732
| -12% | -$4.77M |
|
1030
Aaon
AAON
$7.23B
| $30.4M | ﹤0.01% |
756,848
+3,221
| +0.4% | +$123K |
|
1031
EPAM Systems
EPAM
$5.24B
| $30.4M | ﹤0.01% |
93,887
-21,289
| -18% | -$6.36M |
|
1032
Madison Square Garden
MSGS
$9.94B
| $30.2M | ﹤0.01% |
200,645
+193,153
| +2,578% | +$30.3M |
|
1033
Atkore
ATKR
$3.17B
| $30.2M | ﹤0.01% |
1,327,924
+33,316
| +3% | +$902K |
|
1034
Arcturus Therapeutics
ARCT
$223M
| $30.2M | ﹤0.01% |
703,386
+185,549
| +36% | +$9.21M |
|
1035
TherapeuticsMD
TXMD
$24.1M
| $30.1M | ﹤0.01% |
381,156
-2,282
| -0.6% | -$182K |
|
|
K
1036
DELISTED
Kellanova
K
| $29.9M | ﹤0.01% |
493,783
-14,983
| -3% | -$950K |
|
1037
Matador Resources
MTDR
$6.39B
| $29.7M | ﹤0.01% |
3,595,996
+524,364
| +17% | +$4.7M |
|
1038
FormFactor
FORM
$10.3B
| $29.5M | ﹤0.01% |
1,181,887
+1,149,982
| +3,604% | +$32.1M |
|
1039
Silgan Holdings
SLGN
$4.46B
| $29.4M | ﹤0.01% |
800,421
-128,369
| -14% | -$4.7M |
|
1040
Perdoceo Education
PRDO
$1.99B
| $29.4M | ﹤0.01% |
2,400,919
| – | – |
|
1041
Arcutis Biotherapeutics
ARQT
$3.25B
| $29M | ﹤0.01% |
991,021
-75,519
| -7% | -$2.02M |
|
1042
Intellia Therapeutics
NTLA
$1.66B
| $29M | ﹤0.01% |
1,458,005
+104,691
| +8% | +$2.18M |
|
1043
Crown Holdings
CCK
$12.9B
| $28.9M | ﹤0.01% |
375,834
+315,199
| +520% | +$23.1M |
|
1044
Annexon
ANNX
$862M
| $28.9M | ﹤0.01% |
+954,410
| New | +$22.4M |
|
1045
NewMarket
NEU
$8.72B
| $28.8M | ﹤0.01% |
84,220
-12,691
| -13% | -$4.82M |
|
1046
Fabrinet
FN
$20.3B
| $28.6M | ﹤0.01% |
454,478
+400,910
| +748% | +$26.9M |
|
1047
Douglas Dynamics
PLOW
$967M
| $28.6M | ﹤0.01% |
836,249
+6,178
| +0.7% | +$228K |
|
1048
Hope Bancorp
HOPE
$1.85B
| $28.6M | ﹤0.01% |
3,768,081
-335,960
| -8% | -$2.81M |
|
1049
Ventas
VTR
$46.3B
| $28.4M | ﹤0.01% |
677,576
-23,832
| -3% | -$953K |
|
1050
Hawkins
HWKN
$2.67B
| $28.4M | ﹤0.01% |
1,232,602
-1,200
| -0.1% | -$29.5K |
|
Similar funds
T. Rowe Price Associates's Q3 2020 Portfolio in Review
As of Q3 2020, T. Rowe Price Associates held 2,679 positions worth $864B, up 8.7% from $795B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q3 2020 filing shows 185 new, 873 increased, 1,330 reduced and 90 closed positions. Its largest new stake was nCino: 5,133,240 shares worth $395M. The largest sale was People Inc, an estimated $4.1B.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q3 2020 buy was nCino: 5,133,240 shares worth $395M.
- T. Rowe Price Associates added most to Match Group in Q3 2020, an estimated $3.17B increase.
- T. Rowe Price Associates's biggest Q3 2020 reduction was People Inc, cutting an estimated $4.1B.
- T. Rowe Price Associates fully exited 58.com Inc in Q3 2020, selling an estimated $468M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $864B portfolio in Q3 2020.
- T. Rowe Price Associates opened 185 new positions and closed 90 in Q3 2020.
- T. Rowe Price Associates's portfolio value rose 8.7% quarter-over-quarter to $864B.
Based on T. Rowe Price Associates's 13F filing for Q3 2020, filed 16 Nov 2020.